Ads
related to: bristol squibb myers stock split- Anti-Gold Investor Guide
Investments to buy instead of gold
Free guide to protect your wealth
- Free: Invest Like Buffett
5 "Buffett stocks" to buy right now
New report names 5 wealth-builders
- Planning for Retirement?
Boost to Your Retirement Plan
The 5 Best Stocks for Retirees
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- Anti-Gold Investor Guide
Search results
Results from the Tech24 Deals Content Network
Bristol Myers Squibb stock tanked in April after management lowered the midpoint of its earnings outlook for 2024 from $7.25 per share to just $0.55 to account for a $12.1 billion IPRD charge ...
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Bristol Myers Squibb: A high-yield dividend stock with an attractive valuation. Bristol Myers Squibb, or BMS for short, is another well-established pharmaceutical company with a strong presence in ...
Website. kingpharm .com. King Pharmaceuticals, Inc. is a pharmaceutical company, a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. [1] [2] On October 12, 2010, King was acquired by Pfizer for $14.25 per share. [3]
For premium support please call: 800-290-4726 more ways to reach us
A plan offered in November 2009 would allow shareholders of Bristol-Myers to exchange one dollar of stock in that company for $1.11 worth of shares in Mead Johnson for the 133.5 million shares in the firm, which would value the company at $7.7 billion based on the stock's then current closing price.
Bristol-Myers Squibb (BMY) closed at $60.50 in the latest trading session, marking a -1.59% move from the prior day.
In the latest trading session, Bristol-Myers Squibb (BMY) closed at $63.50, marking a -0.5% move from the previous day.
Ads
related to: bristol squibb myers stock split